Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization

Cancer

Volumn 93, Issue 2, 2001, Pages 165-170

  Tsukamoto, Fumine ^a   Miyoshi, Yasuo ^b   Egawa, Chiyomi ^c   Kasugai, Tsutomu ^a   Takami, Satoshi ^b   Inazawa, Johji ^c   Noguchi, Shinzaburo ^a,d  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c Department of Genetic Diagnosis   (Japan)

^d Tokyo Scientific Research Institute   (Japan)

Author keywords

Aneusomy; Breast tumors; Chromosome; Fluorescence in situ hybridization

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CENTROMERE; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MONOSOMY;

EID: 0035045540     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.9024     Document Type: Article

References (17)

1. Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups
2. Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short-term culture
3. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer
4. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer
5. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization
6. Chromosome-specific aneusomy in carcinoma of the breast
7. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
8. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer
9. Prediction of response to primary chemotherapy for operable breast cancer
10. Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization
11. Interphase cytogenetics of chromosomes 11 and 17 in fine-needle aspirates of breast cancer
12. Chromosome 1 aneusomy with 1p36 under-representation is related to histologic grade, DNA aneuploidy, high c-erb B-2 and loss of bcl-2 expression in ductal breast carcinoma
13. Frequency of chromosome 7 gain in human breast cancer cells: Correlation with the number of metastatic lymph nodes and prognosis
14. DNA ploidy and cell cycle distribution of breast cancer aspirate cells measured by image cytometry and analyzed by artificial neural networks for their prognostic significance
15. Prognostic value from DNA quantification by static cytometry in breast cancer
16. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP-04
17. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: A multivariate analysis of prognostic markers in a series of 308 patients